Back to today’s briefing

Story perspectives

Revolutionary Trial Boosts Hope for Aging Disorders

6/10/2025

29 6

Summary

Story summary

A groundbreaking clinical trial at Chiba University, Japan, has shown that nicotinamide riboside (NR) can significantly boost NAD+ levels in patients with Werner syndrome, a rare disorder that speeds up aging. Participants experienced improved arterial stiffness, smaller skin ulcers, and better kidney function, igniting hope for effective treatments and deeper understanding of aging-related diseases.

1 of 1

Story summary

A groundbreaking clinical trial at Chiba University, Japan, has shown that nicotinamide riboside (NR) can significantly boost NAD+ levels in patients with Werner syndrome, a rare disorder that speeds up aging. Participants experienced improved arterial stiffness, smaller skin ulcers, and better kidney function, igniting hope for effective treatments and deeper understanding of aging-related diseases.